ArticleTrials2025

Implementing oral (event-driven and daily) and long-acting pre-exposure prophylaxis in mobile men in sub-Saharan Africa: a phase 3b, open-label, hybrid type 2 implementation and effectiveness trial (MOBILE MEN).

Sylvia Kusemererwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.